259 related articles for article (PubMed ID: 27666789)
1. Pretreatment with a γ-Secretase Inhibitor Prevents Tumor-like Overgrowth in Human iPSC-Derived Transplants for Spinal Cord Injury.
Okubo T; Iwanami A; Kohyama J; Itakura G; Kawabata S; Nishiyama Y; Sugai K; Ozaki M; Iida T; Matsubayashi K; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2016 Oct; 7(4):649-663. PubMed ID: 27666789
[TBL] [Abstract][Full Text] [Related]
2. Pre-evaluated safe human iPSC-derived neural stem cells promote functional recovery after spinal cord injury in common marmoset without tumorigenicity.
Kobayashi Y; Okada Y; Itakura G; Iwai H; Nishimura S; Yasuda A; Nori S; Hikishima K; Konomi T; Fujiyoshi K; Tsuji O; Toyama Y; Yamanaka S; Nakamura M; Okano H
PLoS One; 2012; 7(12):e52787. PubMed ID: 23300777
[TBL] [Abstract][Full Text] [Related]
3. Treatment with a Gamma-Secretase Inhibitor Promotes Functional Recovery in Human iPSC- Derived Transplants for Chronic Spinal Cord Injury.
Okubo T; Nagoshi N; Kohyama J; Tsuji O; Shinozaki M; Shibata S; Kase Y; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2018 Dec; 11(6):1416-1432. PubMed ID: 30503258
[TBL] [Abstract][Full Text] [Related]
4. In vivo monitoring of remnant undifferentiated neural cells following human induced pluripotent stem cell-derived neural stem/progenitor cells transplantation.
Tanimoto Y; Yamasaki T; Nagoshi N; Nishiyama Y; Nori S; Nishimura S; Iida T; Ozaki M; Tsuji O; Ji B; Aoki I; Jinzaki M; Matsumoto M; Fujibayashi Y; Zhang MR; Nakamura M; Okano H
Stem Cells Transl Med; 2020 Apr; 9(4):465-477. PubMed ID: 31904914
[TBL] [Abstract][Full Text] [Related]
5. Controlling immune rejection is a fail-safe system against potential tumorigenicity after human iPSC-derived neural stem cell transplantation.
Itakura G; Kobayashi Y; Nishimura S; Iwai H; Takano M; Iwanami A; Toyama Y; Okano H; Nakamura M
PLoS One; 2015; 10(2):e0116413. PubMed ID: 25706286
[TBL] [Abstract][Full Text] [Related]
6. LOTUS overexpression via ex vivo gene transduction further promotes recovery of motor function following human iPSC-NS/PC transplantation for contusive spinal cord injury.
Ito S; Nagoshi N; Kamata Y; Kojima K; Nori S; Matsumoto M; Takei K; Nakamura M; Okano H
Stem Cell Reports; 2021 Nov; 16(11):2703-2717. PubMed ID: 34653401
[TBL] [Abstract][Full Text] [Related]
7. Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury.
Kojima K; Miyoshi H; Nagoshi N; Kohyama J; Itakura G; Kawabata S; Ozaki M; Iida T; Sugai K; Ito S; Fukuzawa R; Yasutake K; Renault-Mihara F; Shibata S; Matsumoto M; Nakamura M; Okano H
Stem Cells Transl Med; 2019 Mar; 8(3):260-270. PubMed ID: 30485733
[TBL] [Abstract][Full Text] [Related]
8. Rehabilitative Training Enhances Therapeutic Effect of Human-iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury.
Shibata T; Tashiro S; Shibata S; Shinozaki M; Shindo T; Hashimoto S; Kawai M; Kitagawa T; Ago K; Matsumoto M; Nakamura M; Okano H; Nagoshi N
Stem Cells Transl Med; 2023 Mar; 12(2):83-96. PubMed ID: 36647673
[TBL] [Abstract][Full Text] [Related]
9. γ-secretase inhibitors prevent overgrowth of transplanted neural progenitors derived from human-induced pluripotent stem cells.
Ogura A; Morizane A; Nakajima Y; Miyamoto S; Takahashi J
Stem Cells Dev; 2013 Feb; 22(3):374-82. PubMed ID: 23020188
[TBL] [Abstract][Full Text] [Related]
10. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
Kawai M; Imaizumi K; Ishikawa M; Shibata S; Shinozaki M; Shibata T; Hashimoto S; Kitagawa T; Ago K; Kajikawa K; Shibata R; Kamata Y; Ushiba J; Koga K; Furue H; Matsumoto M; Nakamura M; Nagoshi N; Okano H
Cell Rep; 2021 Nov; 37(8):110019. PubMed ID: 34818559
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the immunogenicity of human iPS cell-derived neural stem/progenitor cells in vitro.
Ozaki M; Iwanami A; Nagoshi N; Kohyama J; Itakura G; Iwai H; Nishimura S; Nishiyama Y; Kawabata S; Sugai K; Iida T; Matsubayashi K; Isoda M; Kashiwagi R; Toyama Y; Matsumoto M; Okano H; Nakamura M
Stem Cell Res; 2017 Mar; 19():128-138. PubMed ID: 28135684
[TBL] [Abstract][Full Text] [Related]
12. Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives.
Itakura G; Kawabata S; Ando M; Nishiyama Y; Sugai K; Ozaki M; Iida T; Ookubo T; Kojima K; Kashiwagi R; Yasutake K; Nakauchi H; Miyoshi H; Nagoshi N; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2017 Mar; 8(3):673-684. PubMed ID: 28262544
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of neural stem/progenitor cells at different locations in mice with spinal cord injury.
Iwai H; Nori S; Nishimura S; Yasuda A; Takano M; Tsuji O; Fujiyoshi K; Toyama Y; Okano H; Nakamura M
Cell Transplant; 2014; 23(11):1451-64. PubMed ID: 23998989
[TBL] [Abstract][Full Text] [Related]
14. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord.
Yasuda A; Tsuji O; Shibata S; Nori S; Takano M; Kobayashi Y; Takahashi Y; Fujiyoshi K; Hara CM; Miyawaki A; Okano HJ; Toyama Y; Nakamura M; Okano H
Stem Cells; 2011 Dec; 29(12):1983-94. PubMed ID: 22028197
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation.
Isoda M; Sanosaka T; Tomooka R; Mabuchi Y; Shinozaki M; Andoh-Noda T; Banno S; Mizota N; Yamaguchi R; Okano H; Kohyama J
Commun Biol; 2023 Jun; 6(1):611. PubMed ID: 37286713
[TBL] [Abstract][Full Text] [Related]
16. Whole-Genome DNA Methylation Analyses Revealed Epigenetic Instability in Tumorigenic Human iPS Cell-Derived Neural Stem/Progenitor Cells.
Iida T; Iwanami A; Sanosaka T; Kohyama J; Miyoshi H; Nagoshi N; Kashiwagi R; Toyama Y; Matsumoto M; Nakamura M; Okano H
Stem Cells; 2017 May; 35(5):1316-1327. PubMed ID: 28142229
[TBL] [Abstract][Full Text] [Related]
17. Safe and efficient method for cryopreservation of human induced pluripotent stem cell-derived neural stem and progenitor cells by a programmed freezer with a magnetic field.
Nishiyama Y; Iwanami A; Kohyama J; Itakura G; Kawabata S; Sugai K; Nishimura S; Kashiwagi R; Yasutake K; Isoda M; Matsumoto M; Nakamura M; Okano H
Neurosci Res; 2016 Jun; 107():20-9. PubMed ID: 26804710
[TBL] [Abstract][Full Text] [Related]
18. A robust culture system to generate neural progenitors with gliogenic competence from clinically relevant induced pluripotent stem cells for treatment of spinal cord injury.
Kamata Y; Isoda M; Sanosaka T; Shibata R; Ito S; Okubo T; Shinozaki M; Inoue M; Koya I; Shibata S; Shindo T; Matsumoto M; Nakamura M; Okano H; Nagoshi N; Kohyama J
Stem Cells Transl Med; 2021 Mar; 10(3):398-413. PubMed ID: 33226180
[TBL] [Abstract][Full Text] [Related]
19. Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury.
Kitagawa T; Nagoshi N; Kamata Y; Kawai M; Ago K; Kajikawa K; Shibata R; Sato Y; Imaizumi K; Shindo T; Shinozaki M; Kohyama J; Shibata S; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2022 Jan; 17(1):127-142. PubMed ID: 35021049
[TBL] [Abstract][Full Text] [Related]
20. Grafted Human iPS Cell-Derived Oligodendrocyte Precursor Cells Contribute to Robust Remyelination of Demyelinated Axons after Spinal Cord Injury.
Kawabata S; Takano M; Numasawa-Kuroiwa Y; Itakura G; Kobayashi Y; Nishiyama Y; Sugai K; Nishimura S; Iwai H; Isoda M; Shibata S; Kohyama J; Iwanami A; Toyama Y; Matsumoto M; Nakamura M; Okano H
Stem Cell Reports; 2016 Jan; 6(1):1-8. PubMed ID: 26724902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]